Post by
knicksman on Dec 01, 2020 7:31am
The Bull Thesis
I know it doesn't feel like there isn't any...but...for fun.
The company started to onboard patients in October. Onboarding accelerated in November. iDocsWeb patients will be onboarded in December. By the time we are midway through Q2, the company will have onboarded ~10k patients @ $50 per month. That means the company will have onboarded 10k patients in about 6 months. Onboarding was never expected to be linear...so lets assume the company onboards another ~20k in the next 8 months. By the end of C21, we could be exiting the year with run-rate revenues of $20 million at 80% gross profit.
They would be able to double that again next year.
Again....bull case...
Comment by
knicksman on Dec 01, 2020 7:40am
For context -- CloudMD will generate about $40 million of revenue in 2021 (50% gross margin) and is valued at $400 million.
Comment by
aaaaaargh on Dec 01, 2020 12:04pm
I always enjoy the work you put into your spread sheets. However, by the time they actually reach those revenues (if they ever do at all), shouldn't the share count be more like 3-400,000,000, seeing as how that is how they pay their bills? The goods news is that the quarterly loss per share will eventually improve to round to 0 as we approach 1 billion shares
Comment by
lscfa on Dec 01, 2020 1:00pm
I'm using a diluted share count so there is an assumption that cash proceeds from exercise of warrants and options will help fund operations.
Comment by
TicTacTo on Dec 20, 2020 7:38am
Joy of small cap and their only interest, rapid surge wave (when happen),but as usual need to book profit. Always surprising on many many many stocks, investors looks price decline by 90% without exiting. In some interview most fund exit around the top above $2 and dump hot patatoes to retails.